Lynas Rare Earths Limited

LYC

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. The company is headquartered in Perth, Western Australia. The Company’s operations include Mt Weld, Lynas Malaysia, Kalgoorlie and Lynas USA. The company focuses on developing the Mt Weld resource, which includes ongoing exploration, production of mixed rare earths concentrates, and an expansion project to increase concentrate feedstock production to support 12,000 tons per annum of finished NdPr oxide. The Lynas Malaysia advanced materials plant is located on a 100-hectare site in the Gebeng Industrial Estate, a purpose-built petrochemical industry zone near Kuantan, on the east coast of Malaysia. Its rare earths processing facility in Kalgoorlie undertakes value-added processing of rare earths. The firm's subsidiaries include Lynas Malaysia Sdn Bhd, Lynas Africa Ltd, Lynas Kalgoorlie Pty Ltd and Lynas USA LLC.

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

CSL

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Morningstar US 'Wide Moat'

MOAT

MOAT.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The VanEck Morningstar Wide Moat ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Morningstar Wide Moat Focus Index.

Catapult Group International Ltd

CAT

Catapult Group International Ltd. engages in the development and supply of wearable athlete tracking and analytics solutions. The company is headquartered in Prahan, Victoria. The company went IPO on 2014-12-19. The Company’s products are designed to optimize performance, avoid injury, and improve return to play. The firm operates through three segments: Performance & Health, Tactics & Coaching and Media & Other. The Performance & Health segment is engaged in the design, development and supply of wearable technology and athlete monitoring software solutions to sports teams, athletes, and the prosumer market. The Tactics & Coaching segment is engaged in the design, development and supply of video analysis, editing, and publishing software solutions to sports teams. The Media & Other segment provides media licensing, athlete management and professional services to customers. Its wearable and video solutions are provided to elite clients on both a subscription and upfront capital sales basis. The firm works with more than 3,800 elite teams in over 40 sports.